A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes

Nicole Porter1, Athena Lerch2, Leonard A Jason

  • 1DePaul University.

Journal of Behavioral and Neuroscience Research
|March 18, 2014
PubMed

Insights

Chronic Fatigue Syndrome (CFS) patients show distinct immune profiles based on viral or non-viral onset. These differences in T-cell subsets suggest a disturbed immune response regulation in CFS patients.

Area of Science:

  • Immunology
  • Cell Biology
  • Virology

Background:

  • Chronic Fatigue Syndrome (CFS) is a complex disorder with poorly understood immune system dysregulation.
  • Understanding immunological differences between viral and non-viral onset CFS may reveal distinct pathogenic mechanisms.

Purpose of the Study:

  • To investigate differential immunological marker expression in CFS patients based on viral versus non-viral onset.
  • To compare phenotypic expression of surface adherence glycoproteins on circulating lymphocytes between these two CFS groups.

Main Methods:

  • Peripheral Blood Mononuclear Cells (PBMCs) were analyzed using flow cytometry.
  • Fluorescent monoclonal antibody labeling was employed to assess surface glycoproteins on lymphocytes.
  • Participants were categorized into viral and non-viral onset fatigue groups.

Main Results:

  • Viral onset CFS showed elevated Th1 subsets (e.g., CD4+ cells, CD2+CD26+ cells) and Th2 naïve cells compared to non-viral onset.
  • Non-viral onset CFS exhibited higher percentages of CD8+ cells, T-cytotoxic suppressor cells, and Th1 memory cells.
  • Both groups displayed reduced Natural Killer Cell Cytotoxicity and B-1 cell percentages, alongside other immune cell subset alterations.

Conclusions:

  • CFS patients exhibit distinct immune activation patterns depending on the onset etiology.
  • Findings suggest a disturbed homeostatic mechanism regulating Th1 (cell-mediated) and Th2 (humoral) immune responses in CFS.
  • These immunological differences may inform targeted therapeutic strategies for CFS.